Formulation and Evaluation of Genistein – A Novel Isoflavone Loaded Chitosan and Eudragit® Nanoparticles for Cancer Therapy

Jain RK. Delivery of Novel Therapeutic Agents in Tumors - Physiological Barriers and Strategies. Journal of the National Cancer Institute 1989; 81,570-6. Sinha R, Kim G, Nie S, Shin D. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular cancer therapeutics 2006; 5(8):1909-17. Cuenca A, Jiang H, Hochwald S, Delano M, Cance W, Grobmyer S. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006; 107(3):459-66. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer 2005; 5(3):161-71. Banerjee S, Li Y, Wang Z, Sarkar F. Multi-targeted therapy of cancer by genistein. Cancer letters 2008; 269(2):226-42. Shah S, Pal A, Kaushik V, Devi S. Preparation and characterization of venlafaxine hydrochloride-loaded chitosan nanoparticles and in vitro release of drug. Journal of applied polymer science 2009; 112(5):2876-87. He P, Davis S, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. International Journal of Pharmaceutics 1998; 166(1):75-88. Shanmuga S, Rekha B, Sridhar S, Sangeetha D. Fabrication of chitosan/TPP nanoparticles as a carrier towards the treatment of cancer. International Journal of Drug Delivery 2013; 5 (1): 35-42. Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad S. Chitosan--Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. International journal of nanomedicine 2012; 7:1851. Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L. Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment. International journal of nanomedicine 2011; 6:2429. Patel N, Patel J, Shah S. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. Acta pharmaceutica 2010; 60(1):39-54.